Generation of mice expressing only the long form of the prolactin receptor reveals that both isoforms of the receptor are required for normal ovarian function

Biology of Reproduction

Volumn 86, Issue 3, 2012, Pages

  Le, Jamie A ^a   Wilson, Heather M ^a   Shehu, Aurora ^a   Mao, Jifang ^a   Devi, Y Sangeeta ^a   Halperin, Julia ^a   Aguilar, Tetley ^a   Seibold, Anita ^a   Maizels, Evelyn ^a   Gibori, Geula ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Corpus luteum; Female infertility; Ovary; Prolactin; Prolactin receptor; Vascularization

Indexed keywords

BETA CASEIN; CCAAT ENHANCER BINDING PROTEIN BETA; COLLAGEN TYPE 4; CYCLIN DEPENDENT KINASE INHIBITOR 1B; ESTROGEN RECEPTOR ALPHA; LONG PROLACTIN RECEPTOR; LUTEINIZING HORMONE RECEPTOR; PROGESTERONE; PROLACTIN RECEPTOR; SHORT PROLACTIN RECEPTOR; STAT5 PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN A; ISOPROTEIN; STAT PROTEIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; CELL DIFFERENTIATION; CELL ISOLATION; CONTROLLED STUDY; CORPUS LUTEUM; EMBRYO; EMBRYO TRANSFER; ENDOTHELIUM CELL; FEMALE; FEMALE FERTILITY; FEMALE INFERTILITY; GRANULOSA CELL; IN VIVO STUDY; LUTEINIZATION; MALE; MATING; MOUSE; NONHUMAN; OVARY FOLLICLE DEVELOPMENT; OVARY FUNCTION; OVULATION; PRIORITY JOURNAL; PROGESTERONE RELEASE; PROGESTERONE SYNTHESIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; VASCULARIZATION; ANIMAL; ANIMAL MODEL; CHEMISTRY; GENETICS; METABOLISM; OVARY; PATHOPHYSIOLOGY; PHYSIOLOGY;

MUS; MUS MUSCULUS;

ANIMALS; CORPUS LUTEUM; FEMALE; INFERTILITY, FEMALE; MICE; MICE, TRANSGENIC; MODELS, ANIMAL; OVARY; PROGESTERONE; PROTEIN ISOFORMS; RECEPTORS, PROLACTIN; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS;

EID: 84860646591     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.111.095927     Document Type: Article

References (64)

1. Morishige WK, Rothchild I. Temporal aspects of the regulation of corpus luteum function by luteinizing hormone, prolactin and placental luteotrophin during the first half of pregnancy in the rat. Endocrinology 1974; 95:260-274.
2. Rothchild I. The regulation of the mammalian corpus luteum. Recent Prog Horm Res 1981; 37:183-298.
3. Gibori G, Khan I, Warshaw ML, McLean MP, Puryear TK, Nelson S, Durkee TJ, Azhar S, Steinschneider A Rao MC. Placental-derived regulators and the complex control of luteal cell function. Recent Prog Horm Res 1988; 44:377-429.
4. Gibori G. The corpus luteum of pregnancy In: Adashi E, Leung P (eds.), The Ovary. New York: Raven Press; 1992:261-317.
5. Murphy BD, Rajkumar K. Prolactin as a luteotrophin. Can J Physiol Pharmacol 1985; 63:257-264.
6. Stocco C, Telleria C, Gibori G. The molecular control of corpus luteum formation, function, and regression. Endocr Rev 2007; 28:117-149.
7. Kalison B, Warshaw ML, Gibori G. Contrasting effects of prolactin on luteal and follicular steroidogenesis. J Endocrinol 1985; 104:241-250.
8. Horseman ND, Zhao W, Montecino-Rodriguez E, Tanaka M, Nakashima K, Engle SJ, Smith F, Markoff E, Dorshkind K. Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO J 1997; 16:6926-6935.
9. Ormandy CJ, Camus A, Barra J, Damotte D, Lucas B, Buteau H, Edery M, Brousse N, Babinet C, Binart N, Kelly PA. Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes Dev 1997; 11:167-178.
10. Binart N, Helloco C, Ormandy CJ, Barra J, Clement-Lacroix P, Baran N, Kelly PA. Rescue of preimplantatory egg development and embryo implantation in prolactin receptor-deficient mice after progesterone administration. Endocrinology 2000; 141:2691-2697.
11. Grosdemouge I, Bachelot A, Lucas A, Baran N, Kelly PA, Binart N. Effects of deletion of the prolactin receptor on ovarian gene expression. Reprod Biol Endocrinol 2003; 1:12.
12. Goffin V, Binart N, Clement-Lacroix P, Bouchard B, Bole-Feysot C, Edery M, Lucas BK, Touraine P, Pezet A, Maaskant R, Pichard C, Helloco C, et al. From the molecular biology of prolactin and its receptor to the lessons learned from knockout mice models. Genet Anal 1999; 15:189-201.
13. Stocco C, Callegari E, Gibori G. Opposite effect of prolactin and prostaglandin F(2 alpha) on the expression of luteal genes as revealed by rat cDNA expression array. Endocrinology 2001; 142:4158-4161.
14. Dajee M, Kazansky AV, Raught B, Hocke GM, Fey GH, Richards JS. Prolactin induction of the alpha 2-Macroglobulin gene in rat ovarian granulosa cells: stat 5 activation and binding to the interleukin-6 response element. Mol Endocrinol 1996; 10:171-184.
15. Gaddy-Kurten D, Hickey GJ, Fey GH, Gauldie J, Richards JS. Hormonal regulation and tissue-specific localization of alpha 2-macroglobulin in rat ovarian follicles and corpora lutea. Endocrinology 1989; 125:2985-2995.
16. Gaddy-Kurten D, Richards JS. Regulation of alpha 2-macroglobulin by luteinizing hormone and prolactin during cell differentiation in the rat ovary. Mol Endocrinol 1991; 5:1280-1291.
17. Russell DL, Norman RL, Dajee M, Liu X, Hennighausen L, Richards JS. Prolactin-induced activation and binding of stat proteins to the IL-6RE of the alpha 2-macroglobulin (alpha 2M) promoter: relation to the expression of alpha 2M in the rat ovary. Biol Reprod 1996; 55:1029-1038.
18. Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev 1998; 19:225-268.
19. Russell DL, Richards JS. Differentiation-dependent prolactin responsiveness and stat (signal transducers and activators of transcription) signaling in rat ovarian cells. Mol Endocrinol 1999; 13:2049-2064.
20. Telleria CM, Parmer TG, Zhong L, Clarke DL, Albarracin CT, Duan WR, Linzer DI, Gibori G. The different forms of the prolactin receptor in the rat corpus luteum: developmental expression and hormonal regulation in pregnancy. Endocrinology 1997; 138:4812-4820.
21. Binart N, Imbert-Bollore P, Baran N, Viglietta C, Kelly PA. A short form of the prolactin (PRL) receptor is able to rescue mammopoiesis in heterozygous PRL receptor mice. Mol Endocrinol 2003; 17:1066-1074.
22. Halperin J, Devi SY, Elizur S, Stocco C, Shehu A, Rebourcet D, Unterman TG, Leslie ND, Le J, Binart N, Gibori G. Prolactin signaling through the short form of its receptor represses forkhead transcription factor FOXO3 and its target gene galt causing a severe ovarian defect. Mol Endocrinol 2008; 22:513-522.
23. Devi YS, Seibold A, Shehu A, Maizels E, Halperin J, Le J, Binart N, Bao L, Gibori G. Inhibition of MAPK by prolactin signaling through the short form of its receptor in the ovary and decidua: involvement of a novel phosphatase. J Biol Chem 2011; 286:7609-7618.
24. Devi YS, Shehu A, Halperin J, Stocco C, Le J, Seibold AM, Gibori G. Prolactin signaling through the short isoform of the mouse prolactin receptor regulates DNA binding of specific transcription factors, often with opposite effects in different reproductive issues. Reprod Biol Endocrinol 2009; 7:87.
25. Devi YS, Shehu A, Stocco C, Halperin J, Le J, Seibold AM, Lahav M, Binart N, Gibori G. Regulation of transcription factors and repression of Sp1 by prolactin signaling through the short isoform of its cognate receptor. Endocrinology 2009; 150:3327-3335.
26. Gouilleux F, Wakao H, Mundt M, Groner B. Prolactin induces phosphorylation of Tyr694 of Stat5 (MGF), a prerequisite for DNA binding and induction of transcription. Embo J 1994; 13:4361-4369.
27. Chang WP, Clevenger CV. Modulation of growth factor receptor function by isoform heterodimerization. Proc Natl Acad Sci U S A 1996; 93:5947-4952.
28. Chang WP, Ye Y, Clevenger CV. Stoichiometric structure-function analysis of the prolactin receptor signaling domain by receptor chimeras. Mol Cell Biol 1998; 18:896-905.
29. Frasor J, Barkai U, Zhong L, Fazleabas AT, Gibori G. PRL-induced ERalpha gene expression is mediated by Janus kinase 2 (Jak2) while signal transducer and activator of transcription 5b (Stat5b) phosphorylation involves Jak2 and a second tyrosine kinase. Mol Endocrinol 2001; 15:1941-1952.
30. Udy GB, Towers RP, Snell RG, Wilkins RJ, Park SH, Ram PA, Waxman DJ, Davey HW. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci U S A 1997;94:7239-7244.
31. Bachelot A, Binart N. Corpus luteum development: lessons from genetic models in mice. Curr Top Dev Biol 2005; 68:49-84.
32. Zhong L, Parmer TG, Robertson MC, Gibori G. Prolactin-mediated inhibition of 20alpha-hydroxysteroid dehydrogenase gene expression and the tyrosine kinase system. Biochem Biophys Res Commun 1997; 235:587-592.
33. Ricken AM, Traenkner A, Merkwitz C, Hummitzsch K, Grosche J, Spanel-Borowski K. The short prolactin receptor predominates in endothelial cells of micro- and macrovascular origin. J Vasc Res 2007;44:19-30.
34. Sugino N, Zilberstein M, Srivastava RK, Telleria CM, Nelson SE, Risk M, Chou JY, Gibori G. Establishment and characterization of a simian virus 40-transformed temperature-sensitive rat luteal cell line. Endocrinology 1998; 139:1936-1942.
35. Shehu A, Mao J, Gibori GB, Halperin J, Le J, Devi YS, Merrill B, Kiyokawa H, Gibori G. Prolactin receptor-associated protein/17betahydroxysteroid dehydrogenase type 7 gene (Hsd17b7) plays a crucial role in embryonic development and fetal survival. Mol Endocrinol 2008; 22:2268-2277.
36. Eppig JJ, Wigglesworth K, Pendola F, Hirao Y. Murine oocytes suppress expression of luteinizing hormone receptor messenger ribonucleic acid by granulosa cells. Biol Reprod 1997; 56:976-984.
37. Fan HY, Liu Z, Shimada M, Sterneck E, Johnson PF, Hedrick SM, Richards JS. MAPK3/1 (ERK1/2) in ovarian granulosa cells are essential for female fertility. Science 2009; 324:938-941.
38. Shehu A, Albarracin C, Devi YS, Luther K, Halperin J, Le J, Mao J, Duan RW, Frasor J, Gibori G. The stimulation of HSD17B7 expression by estradiol provides a powerful feed-forward mechanism for estradiol biosynthesis in breast cancer cells. Mol Endocrinol 2011; 25:754-766.
39. Bjurulf E, Selstam G, Olofsson JI. Increased LH receptor mRNA and extended corpus luteum function induced by prolactin and indomethacin treatment in vivo in hysterectomized pseudopregnant rats. J Reprod Fertil 1994; 102:139-145.
40. Segaloff DL, Wang HY, Richards JS. Hormonal regulation of luteinizing hormone/chorionic gonadotropin receptor mRNA in rat ovarian cells during follicular development and luteinization. Mol Endocrinol 1990; 4:1856-1865.
41. Berlanga JJ, Garcia-Ruiz JP, Perrot-Applanat M, Kelly PA, Edery M. The short form of the prolactin (PRL) receptor silences PRL induction of the beta-casein gene promoter. Mol Endocrinol 1997; 11:1449-1457.
42. Lesueur L, Edery M, Ali S, Paly J, Kelly PA, Djiane J. Comparison of long and short forms of the prolactin receptor on prolactin-induced milk protein gene transcription. Proc Natl Acad Sci U S A 1991; 88:824-828.
43. Clarke DL, Linzer DI. Changes in prolactin receptor expression during pregnancy in the mouse ovary. Endocrinology 1993; 133:224-232.
44. Frasor J, Park K, Byers M, Telleria C, Kitamura T, Yu-Lee LY, Djiane J, Park-Sarge OK, Gibori G. Differential roles for signal transducers and activators of transcription 5a and 5b in PRL stimulation of ERalpha and ERbeta transcription. Mol Endocrinol 2001; 15:2172-2181.
45. Gafvels M, Bjurulf E, Selstam G. Prolactin stimulates the expression of luteinizing hormone/chorionic gonadotropin receptor messenger ribonucleic acid in the rat corpus luteum and rescues early pregnancy from bromocriptine-induced abortion. Biol Reprod 1992; 47:534-540.
46. Bao L, Tessier C, Prigent-Tessier A, Li F, Buzzio OL, Callegari EA, Horseman ND, Gibori G. Decidual prolactin silences the expression of genes detrimental to pregnancy. Endocrinology 2007; 148:2326-2334.
47. Fraser HM, Wulff C. Angiogenesis in the corpus luteum. Reprod Biol Endocrinol 2003; 1:88.
48. Hudson BG, Reeders ST, Tryggvason K. Type IV collagen: structure, gene organization, and role in human diseases. Molecular basis of Goodpasture and Alport syndromes and diffuse leiomyomatosis. J Biol Chem 1993; 268:26033-26036.
49. Wang H, Su Y. Collagen IV contributes to nitric oxide-induced angiogenesis of lung endothelial cells. Am J Physiol Cell Physiol 2011;300:C979-C988.
50. Bonanno E, Iurlaro M, Madri JA, Nicosia RF. Type IV collagen modulates angiogenesis and neovessel survival in the rat aorta model. In Vitro Cell Dev Biol Anim 2000; 36:336-340.
51. Nicosia RF, Madri JA. The microvascular extracellular matrix. Developmental changes during angiogenesis in the aortic ring-plasma clot model. Am J Pathol 1987; 128:78-90.
52. Martel C, Labrie C, Dupont E, Couet J, Trudel C, Rheaume E, Simard J, Luu-The V, Pelletier G, Labrie F. Regulation of 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase expression and activity in the hypophysectomized rat ovary: interactions between the stimulatory effect of human chorionic gonadotropin and the luteolytic effect of prolactin. Endocrinology 1990; 127:2726-2737.
53. Kaynard AH, Periman LM, Simard J, Melner MH. Ovarian 3 betahydroxysteroid dehydrogenase and sulfated glycoprotein-2 gene expression are differentially regulated by the induction of ovulation, pseudopregnancy, and luteolysis in the immature rat. Endocrinology 1992; 130:2192-2200.
54. Risk M, Gibori G. Mechanisms of luteal cell regulation by prolactin In: H. ND (ed.), Prolactin. Boston: Kluwer Academic Publishers; 2001:265-295.
55. Frasor J, Gibori G. Prolactin regulation of estrogen receptor expression. Trends Endocrinol Metab 2003; 14:118-123.
56. Gadd SL, Clevenger CV. Ligand-independent dimerization of the human prolactin receptor isoforms: functional implications. Mol Endocrinol 2006;20:2734-2746.
57. Qazi AM, Tsai-Morris CH, Dufau ML. Ligand-independent homo- and hetero-dimerization of human prolactin receptor variants: inhibitory action of the short forms by heterodimerization. Mol Endocrinol 2006; 20:1912-1923.
58. McLean MP, Nelson S, Parmer T, Khan I, Steinschneider A, Puryear T, Gibori G. Identification and characterization of an abundant phosphoprotein specific to the large luteal cell. Endocrinology 1990; 126:1796-1805.
59. Duan WR, Linzer DI, Gibori G. Cloning and characterization of an ovarian-specific protein that associates with the short form of the prolactin receptor. J Biol Chem 1996; 271:15602-15607.
60. Ferrara N, Chen H, Davis-Smyth T, Gerber HP, Nguyen TN, Peers D, Chisholm V, Hillan KJ, Schwall RH. Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nat Med 1998; 4:336-340.
61. Cebe-Suarez S, Zehnder-Fjallman A, Ballmer-Hofer K. The role of VEGF receptors in angiogenesis; complex partnerships. Cell Mol Life Sci 2006;63:601-615.
62. Fraser HM, Lunn SF. Regulation and manipulation of angiogenesis in the primate corpus luteum. Reproduction 2001; 121:355-362.
63. Perrot-Applanat M, Gualillo O, Pezet A, Vincent V, Edery M, Kelly PA. Dominant negative and cooperative effects of mutant forms of prolactin receptor. Mol Endocrinol 1997; 11:1020-1032.
64. Saunier E, Dif F, Kelly PA, Edery M. Targeted expression of the dominant-negative prolactin receptor in the mammary gland of transgenic mice results in impaired lactation. Endocrinology 2003; 144:2669-2675.